These two loci, combined with the other two known loci, HLA‐A amino acid Gln in site 62 and rs2894207 (located in intergenic region of HLA‐B and HLA‐C), made a cumulative contribution to NPC risk and explained 2.07% of NPC susceptibility. This evidence concerns the gene HLA-B and nasopharyngeal carcinoma.